Both can be microdosed
Diabetes 47(11):16631670 Jeng C-J, Hsieh Y-T, Yang C-M, Yang C-H, Lin C-L, Wang I-J (2018) Diabetic retinopathy in patients with dyslipidemia: development and progression
Results Expectations Many patients ask how soon they can see results
But on GLP-1 medication, the enhanced satiety signaling partially compensates for lower leptin levels
Serious but rare adverse effects that require immediate medical attention include: Acute pancreatitis: Characterised by severe, persistent abdominal pain radiating to the back, often accompanied by nausea and vomiting Gallbladder disease: Including cholecystitis and cholelithiasis, presenting with right upper quadrant pain Acute kidney injury: Particularly in patients experiencing severe gastrointestinal symptoms leading to dehydration Severe allergic reactions: Anaphylaxis, angioedema, or severe skin reactions Diabetic retinopathy complications: Rapid improvement in glycaemic control may temporarily worsen diabetic eye disease Regarding swollen lymph nodes specifically , there is no established causal link between tirzepatide and lymphadenopathy in the current evidence base
Share your interest in GLP-1 medications and discuss how the combination will be managed
